These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 15953264)
1. Behavioral research and the double-blind placebo-controlled methodology: challenges in applying the biomedical standard to behavioral headache research. Rains JC; Penzien DB Headache; 2005 May; 45(5):479-86. PubMed ID: 15953264 [TBL] [Abstract][Full Text] [Related]
2. Guidelines for trials of behavioral treatments for recurrent headache, first edition: American Headache Society Behavioral Clinical Trials Workgroup. Penzien DB; Andrasik F; Freidenberg BM; Houle TT; Lake AE; Lipchik GL; Holroyd KA; Lipton RB; McCrory DC; Nash JM; Nicholson RA; Powers SW; Rains JC; Wittrock DA; Headache; 2005 May; 45 Suppl 2():S110-32. PubMed ID: 15921503 [TBL] [Abstract][Full Text] [Related]
5. Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity. Colagiuri B Clin Trials; 2010 Jun; 7(3):246-55. PubMed ID: 20421243 [TBL] [Abstract][Full Text] [Related]
6. [Roaming through methodology. XXIII. The need for randomization and blinding in therapeutic investigations]. Knipschild PG Ned Tijdschr Geneeskd; 2000 Sep; 144(38):1826-8. PubMed ID: 11020835 [TBL] [Abstract][Full Text] [Related]
8. Future directions in behavioral headache research: applications for an evolving health care environment. Penzien DB; Rains JC; Lipchik GL; Nicholson RA; Lake AE; Hursey KG Headache; 2005 May; 45(5):526-34. PubMed ID: 15953270 [TBL] [Abstract][Full Text] [Related]
9. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia. Woods SW; Gueorguieva RV; Baker CB; Makuch RW Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728 [TBL] [Abstract][Full Text] [Related]
10. Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment. Licciardone JC; Russo DP J Am Osteopath Assoc; 2006 Aug; 106(8):457-63. PubMed ID: 16943515 [TBL] [Abstract][Full Text] [Related]
11. Redefining the randomized controlled trial in the context of acupuncture research. Walji R; Boon H Complement Ther Clin Pract; 2006 May; 12(2):91-6. PubMed ID: 16648085 [TBL] [Abstract][Full Text] [Related]
12. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Riemann D; Perlis ML Sleep Med Rev; 2009 Jun; 13(3):205-14. PubMed ID: 19201632 [TBL] [Abstract][Full Text] [Related]
14. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
15. Assessing the reporting and scientific quality of meta-analyses of randomized controlled trials of treatments for anxiety disorders. Bereza BG; Machado M; Einarson TR Ann Pharmacother; 2008 Oct; 42(10):1402-9. PubMed ID: 18728102 [TBL] [Abstract][Full Text] [Related]
16. The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials. Wampold BE; Minami T; Tierney SC; Baskin TW; Bhati KS J Clin Psychol; 2005 Jul; 61(7):835-54. PubMed ID: 15827993 [TBL] [Abstract][Full Text] [Related]
17. Methodological issues in clinical trials of drug and behavior therapies. Holroyd KA; Powers SW; Andrasik F Headache; 2005 May; 45(5):487-92. PubMed ID: 15953265 [TBL] [Abstract][Full Text] [Related]
18. Moderators and mediators of behavioral treatment for headache. Nicholson RA; Hursey KG; Nash JM Headache; 2005 May; 45(5):513-9. PubMed ID: 15953268 [TBL] [Abstract][Full Text] [Related]
19. Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality. Gomberg-Maitland M; Frison L; Halperin JL Am Heart J; 2003 Sep; 146(3):398-403. PubMed ID: 12947355 [TBL] [Abstract][Full Text] [Related]